Episode Details
Back to Episodes
Doing Things Differently: YARAL Pharma, Pennsylvania Policy, and the Birth Control Pharmacist | TWIRx
Episode 2426
Published 1Â day, 11Â hours ago
Description
🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026
Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.Â
✅ Today’s Sponsor: YARAL Pharma
YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.Â
📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers.
https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill
2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care.
https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trustedÂ
3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management.
https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html
4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide.
https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/Â
🎤 Interviews & Segm
Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.Â
✅ Today’s Sponsor: YARAL Pharma
YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.Â
📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers.
https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill
2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care.
https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trustedÂ
3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management.
https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html
4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide.
https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/Â
🎤 Interviews & Segm